Lalonde James

Avg. Two Year Performance

No purchase track record
10% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)(7%)(1%)10%10%
Sale Success Rate3 of 73 of 73 of 74 of 74 of 7

Codexis, Inc.

Drugs » Biotechnology

SVP, R&D:

Holdings: 133.4K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--